CVAC
Income statement / Annual
Last year (2024), CureVac N.V.'s total revenue was $535.18 M,
an increase of 895.54% from the previous year.
In 2024, CureVac N.V.'s net income was $162.19 M.
See CureVac N.V.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$535.18 M |
$53.76 M |
$67.42 M |
$102.99 M |
$48.90 M |
$17.42 M |
$12.87 M |
| Cost of Revenue |
$105.83 M
|
$124.37 M
|
$183.99 M
|
$238.20 M
|
$14.17 M
|
$27.98 M
|
$17.74 M
|
| Gross Profit |
$429.35 M
|
-$70.61 M
|
-$116.57 M
|
-$135.21 M
|
$34.73 M
|
-$10.57 M
|
-$4.87 M
|
| Gross Profit Ratio |
0.8
|
-1.31
|
-1.73
|
-1.31
|
0.71
|
-0.61
|
-0.38
|
| Research and Development Expenses |
$153.03 M
|
$115.72 M
|
$62.55 M
|
$815.91 M
|
$113.81 M
|
$43.24 M
|
$41.72 M
|
| General & Administrative Expenses |
$56.38 M
|
$76.01 M
|
$88.99 M
|
$87.20 M
|
$45.03 M
|
$42.18 M
|
$20.42 M
|
| Selling & Marketing Expenses |
$4.45 M
|
$424,000.00
|
$417,000.00
|
$1.74 M
|
$733,000.00
|
$1.76 M
|
$1.09 M
|
| Selling, General & Administrative Expenses |
$60.82 M
|
$76.43 M
|
$89.41 M
|
$88.94 M
|
$45.76 M
|
$43.94 M
|
$21.50 M
|
| Other Expenses |
$37.81 M
|
$11.44 M
|
-$17.68 M
|
-$627.79 M
|
-$870,000.00
|
$1.75 M
|
$4.73 M
|
| Operating Expenses |
$251.67 M
|
$203.60 M
|
$134.28 M
|
$277.06 M
|
$158.70 M
|
$88.93 M
|
$67.95 M
|
| Cost And Expenses |
$357.50 M
|
$327.97 M
|
$318.27 M
|
$515.25 M
|
$158.70 M
|
$116.91 M
|
$85.70 M
|
| Interest Income |
$12.36 M
|
$16.73 M
|
$4.01 M
|
$10.10 M
|
$2.07 M
|
$833,000.00
|
$1.97 M
|
| Interest Expense |
$0.00
|
$2.49 M
|
$3.71 M
|
$10.34 M
|
$22.10 M
|
$1.46 M
|
$275,000.00
|
| Depreciation & Amortization |
$18.81 M
|
$23.39 M
|
$26.16 M
|
$35.88 M
|
$13.61 M
|
$4.76 M
|
$3.89 M
|
| EBITDA |
$209.69 M |
-$234.09 M |
-$209.39 M |
-$386.49 M |
-$123.10 M |
-$91.50 M |
-$69.85 M |
| EBITDA Ratio |
0.39
|
-4.35
|
-3.11
|
-3.75
|
-2.52
|
-5.25
|
-5.43
|
| Operating Income Ratio |
0.33
|
-5.1
|
-3.7
|
-4
|
-2.54
|
-5.71
|
-5.66
|
| Total Other Income/Expenses Net |
$13.20 M
|
$14.24 M
|
$302,000.00
|
-$235,000.00
|
-$20.03 M
|
-$627,000.00
|
$1.69 M
|
| Income Before Tax |
$190.88 M
|
-$259.97 M
|
-$249.16 M
|
-$412.50 M
|
-$129.80 M
|
-$100.13 M
|
-$71.13 M
|
| Income Before Tax Ratio |
0.36
|
-4.84
|
-3.7
|
-4.01
|
-2.65
|
-5.75
|
-5.53
|
| Income Tax Expense |
$28.70 M
|
$198,000.00
|
-$126,000.00
|
-$782,000.00
|
-$726,000.00
|
-$252,000.00
|
$110,000.00
|
| Net Income |
$162.19 M
|
-$260.17 M
|
-$249.03 M
|
-$411.72 M
|
-$129.07 M
|
-$99.87 M
|
-$71.24 M
|
| Net Income Ratio |
0.3
|
-4.84
|
-3.69
|
-4
|
-2.64
|
-5.73
|
-5.54
|
| EPS |
0.72 |
-1.18 |
-1.32 |
-2.21 |
-0.98 |
-0.53 |
-0.4 |
| EPS Diluted |
0.72 |
-1.18 |
-1.32 |
-2.21 |
-0.98 |
-0.53 |
-0.4 |
| Weighted Average Shares Out |
$224.38 M
|
$220.48 M
|
$189.07 M
|
$186.01 M
|
$132.20 M
|
$186.91 M
|
$175.97 M
|
| Weighted Average Shares Out Diluted |
$225.27 M
|
$220.83 M
|
$189.07 M
|
$186.01 M
|
$132.20 M
|
$186.91 M
|
$175.97 M
|
| Link |
|
|
|
|
|
|
|
